A 4852 — New Jersey
Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*
New Jersey legislative agenda & upcoming votes New Jersey session calendar
Summary
- A 4852 is a bill in the New Jersey General Assembly, 222 session, introduced May 4, 2026.
- Sponsored by Katz, Andrea, Sweeney, Marisa, Kearney, Vincent M., Tully, Chris, Vitale, Joseph F., Gopal, Vin, and Mukherji, Raj, with 2 cosponsors.
- Current status: signed into law.
- Most recent action (July 8, 2026): Approved P.L.2026, c.40.
- 3 recorded votes; the most recent, on June 30, 2026, passed 38-2.
-
State Representative, District 8
Democratic -
State Representative, District 38
Democratic -
State Senator, District 19
Democratic -
State Senator, District 11
Democratic -
State Senator, District 32
Democratic
Contact your legislator about this bill
Bill text & documents
Sponsors
Primary: Katz, Andrea, Sweeney, Marisa, Kearney, Vincent M., Tully, Chris, Vitale, Joseph F., Gopal, Vin, Mukherji, Raj
Cosponsors (2): Karabinchak, Robert J., Donlon, Margie, M.D.
History
- Introduced, completed
- Passed General Assembly, completed
- Passed Senate, completed
- Sent to Governor, completed
- Signed into law, completed, current stage
- General Assembly Introduced, Referred to Assembly Health Committee Milestone
- General Assembly Transferred to Assembly State and Local Government Committee
-
General Assembly
Reported from Assembly Comm. as a Substitute, 2nd Reading
Reported out of Assembly committee as a substitute: 7 yes 0 no Passed, 100% yes
-
General Assembly
Passed by the Assembly (76-2-1)
Milestone
3RDG FINAL PASSAGE: 76 yes 2 no, 2 other Passed, 97% yes
- Senate Received in the Senate without Reference, 2nd Reading
- General Assembly Substituted for S4194/4210 (SCS)
-
Senate
Passed Senate (Passed Both Houses) (38-2)
Milestone
3RDG FINAL PASSAGE: 38 yes 2 no Passed, 95% yes
- General Assembly Approved P.L.2026, c.40. Milestone Latest